• 2022-06-07
    Assuming that a vaccine against hepatitis C was developed. To evaluate the effectiveness of this vaccine, the population that should be selected as the research object is
    A: People infected with hepatitis C
    B: People with low incidence of hepatitis C
    C: People who have been infected with hepatitis C and have antibodies in their bodies
    D: High-risk population of hepatitis C
    E: People who have been infected with hepatitis B